Table 1 Baseline characteristics
Variable | Psychotropic recipients (n = 306,470) | Non-psychotropic recipientsa (n = 371,800) | Standardized Difference |
|---|---|---|---|
Age (median, IQR) | 18 (14–21) | 12 (6–19) | 0.75 |
 0–4 | 1175 (0.4%) | 66,067 (17.8%) | 0.63 |
 5–9 | 30,060 (9.8%) | 76,377 (20.5%) | 0.30 |
 10–14 | 50,826 (16.6%) | 76,773 (20.6%) | 0.10 |
 15–19 | 98,517 (32.1%) | 72,626 (19.5%) | 0.29 |
 20–24 | 125,892 (41.1%) | 79,957 (21.5%) | 0.43 |
Female, No. (%) | 159,740 (52.1%) | 179,670 (48.3%) | 0.08 |
Income quintile | |||
 1 (lowest) | 62,279 (20.3%) | 73,710 (19.8%) | 0.01 |
 2 | 57,947 (18.9%) | 68,804 (18.5%) | 0.01 |
 3 | 57,269 (18.7%) | 73,995 (19.9%) | 0.03 |
 4 | 60,796 (19.8%) | 77,411 (20.8%) | 0.02 |
 5 | 68,179 (22.2%) | 77,880 (20.9%) | 0.03 |
Residence | |||
 Urban | 271,467 (88.6%) | 336,659 (90.5%) | 0.06 |
 Rural | 35,003 (11.4%) | 35,141 (9.5%) | 0.06 |
ADG Category | |||
 0–5 | 147,812 (48.2%) | 272,240 (73.2%) | 0.53 |
 6–9 | 111,880 (36.5%) | 84,390 (22.7%) | 0.31 |
  > 10 | 46,778 (15.3%) | 15,170 (4.1%) | 0.39 |